Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Omics Data-Derived Inflammatory Phenotype for ABPA Recurrence Risk Prediction: A Multicenter Study

NCT07611838 is registered in ClinicalTrials.gov with Qianfoshan Hospital as lead sponsor.

NCT NCT07611838
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07611838 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Omics Data-Derived Inflammatory Phenotype for ABPA Recurrence Risk Prediction: A Multicenter Study
Lead sponsor
Qianfoshan Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2021
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic bronchopulmonary aspergillosis (abpa), machine learning, multi-omics, multicenter study, relapse